bpc-157 compounding restrictions fda Exciting news for peptides coming out of today's committee hearing! The Pharmacy Advisory Committee voted 8-6 to recommend adding BPC- 157 to the 503A Bulks List for use in compounding for BPC 157 approved by FDA
BPC 157 approved by FDA today to add as a compounded substance : r PeptidePathways Hims & Hers Stock Jumps as FDA Panel Opens the Door to a Multibillion Dollar Peptide Market PRISM MarketView FDA panel votes to place popular peptide BPC 157 on compounding list Reuters BREAKING: The FDA just reversed theIR 2023 peptide ban. 12 peptides were just pulled from the Category 2 restricted list: 1. BPC 157 2. Thymosin beta 4 fragment (TB 500) 3. Epitalon 4. GHK Cu (injectable)
Pay in 4 interest-free payments of $6.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17


